Cargando…
CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis
BACKGROUND: Endometrial cancer (EC) is the most common malignancy of the female reproductive tract. Despite years of research, the accurate screening strategy is still not available in this disease and it is usually diagnosed only after the clinical signs are present. The recent technological advanc...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489287/ https://www.ncbi.nlm.nih.gov/pubmed/31035965 http://dx.doi.org/10.1186/s12885-019-5556-x |